OCUGEN, INC. Payments of Stock Issuance Costs
OCUGEN, INC. (OCGN) reported Payments of Stock Issuance Costs of $1.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-06
- OCUGEN, INC. payments of stock issuance costs for the quarter ending 2026-06-30 was $0.00.
- OCUGEN, INC. payments of stock issuance costs for the quarter ending 2026-03-31 was $1.78M.
- OCUGEN, INC. payments of stock issuance costs for the quarter ending 2025-06-30 was $0.00.
- OCUGEN, INC. payments of stock issuance costs for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- OCUGEN, INC. payments of stock issuance costs for fiscal 2025 was $1.53M, a 47.18% decline from fiscal 2024.
- OCUGEN, INC. payments of stock issuance costs for fiscal 2024 was $2.89M, a 713.80% increase from fiscal 2023.
- OCUGEN, INC. payments of stock issuance costs for fiscal 2023 was $355.00K, a 35.34% decline from fiscal 2022.
- OCUGEN, INC. payments of stock issuance costs for fiscal 2022 was $549.00K, a 93.56% decline from fiscal 2021.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 3 month as first filed | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 6 month as first filed | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 9 month as first filed | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.78M 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | $1.78M 10-Q · filed 2026-05-08 | |||||||
| 2025-12-31 | $1.53M 10-K · filed 2026-03-04 | |||||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $184.00K 10-Q · filed 2025-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $2.79M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 | $245.00K 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $2.79M derived: sum of 3 quarters · filed 2026-05-08 | $2.74M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.79M derived: sum of 2 quarters · filed 2026-03-04 | $2.74M derived: sum of 3 quarters · filed 2026-03-04 | $2.89M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.74M derived: sum of 2 quarters · filed 2025-08-04 | $2.89M 10-Q · filed 2024-11-14 | $2.89M derived: sum of 4 quarters · filed 2025-08-04 | ||||
| 2024-06-30 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $100.00K 10-Q · filed 2025-08-04 | $0.00 10-Q · filed 2024-08-08 | $100.00K derived: sum of 3 quarters · filed 2025-08-04 | $233.00K derived: sum of 4 quarters · filed 2025-08-04 | |||
| 2024-03-31 | $145.00K 10-Q · filed 2025-05-09 | $0.00 10-Q · filed 2024-05-14 | $145.00K derived: sum of 2 quarters · filed 2025-05-09 | $278.00K derived: sum of 3 quarters · filed 2025-05-09 | $327.00K derived: sum of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $133.00K derived: sum of 2 quarters · filed 2025-03-05 | $182.00K derived: sum of 3 quarters · filed 2025-03-05 | $355.00K 10-K · filed 2025-03-05 | ||||
| 2023-09-30 | $133.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $182.00K derived: sum of 2 quarters · filed 2024-11-14 | $355.00K 10-Q · filed 2024-11-14 | $606.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $222.00K 10-Q · filed 2024-08-08 | $473.00K derived: sum of 3 quarters · filed 2024-08-08 | $571.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $173.00K 10-Q · filed 2024-05-14 | $424.00K derived: sum of 2 quarters · filed 2024-05-14 | $522.00K derived: sum of 3 quarters · filed 2024-05-14 | $647.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $251.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-04-16 | $349.00K derived: sum of 2 quarters · filed 2024-04-16 | $474.00K derived: sum of 3 quarters · filed 2024-04-16 | $549.00K 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | $98.00K derived: 10-K 9 month − 10-K 6 month · filed 2024-04-16 | $223.00K derived: sum of 2 quarters · filed 2024-04-16 | $298.00K 10-K · filed 2024-04-16 | $298.00K derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2022-06-30 | $125.00K derived: 10-K 6 month − 10-K 3 month · filed 2024-04-16 | $200.00K 10-K · filed 2024-04-16 | $200.00K derived: sum of 3 quarters · filed 2024-04-16 | $200.00K derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2022-03-31 | $75.00K 10-K · filed 2024-04-16 | $75.00K derived: sum of 2 quarters · filed 2024-04-16 | $75.00K derived: sum of 3 quarters · filed 2024-04-16 | $6.78M derived: sum of 4 quarters · filed 2024-04-16 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $0.00 derived: sum of 2 quarters · filed 2023-02-28 | $6.70M derived: sum of 3 quarters · filed 2023-02-28 | $8.53M 10-K · filed 2023-02-28 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $6.70M derived: sum of 2 quarters · filed 2022-11-08 | $8.53M 10-Q · filed 2022-11-08 | $8.92M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $8.53M 10-Q · filed 2022-08-05 | $8.92M derived: sum of 3 quarters · filed 2022-08-05 | $9.41M derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2021-03-31 | $1.82M 10-Q · filed 2022-05-06 | $2.21M derived: sum of 2 quarters · filed 2022-05-06 | $2.71M derived: sum of 3 quarters · filed 2022-05-06 | $3.30M derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $884.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.48M derived: sum of 3 quarters · filed 2022-02-28 | $1.48M 10-K · filed 2022-02-28 | $1.48M 10-K · filed 2021-03-19 | |||
| 2020-09-30 | $491.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.08M derived: sum of 2 quarters · filed 2021-11-09 | $1.08M 10-Q · filed 2021-11-09 | $1.08M 10-Q · filed 2020-11-06 | $434.75K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $593.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $593.00K 10-Q · filed 2021-08-06 | $592.95K 10-Q · filed 2020-08-14 | -$56.25K derived: sum of 3 quarters · filed 2022-02-28 | $593.00K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | -$649.25K derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | |||||
| 2019-12-31 | -$649.25K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | |||||
| 2019-09-30 | $649.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $649.25K 10-Q · filed 2020-11-06 | ||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 | |||||||
| 2018-09-30 | $635.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $635.18K derived: sum of 2 quarters · filed 2019-11-12 | $741.18K 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $106.00K 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | $106.00K 10-Q · filed 2019-05-15 | |||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $377.00K 10-K · filed 2017-03-16 | |||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $377.00K 10-Q · filed 2016-11-10 | ||||||
| 2016-06-30 | $377.00K 10-Q · filed 2016-08-11 | |||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$304.00K derived: sum of 2 quarters · filed 2015-11-12 | $73.00K 10-Q · filed 2015-11-12 | $73.00K derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2015-06-30 | -$304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $73.00K 10-Q · filed 2015-08-12 | $73.00K derived: sum of 3 quarters · filed 2016-05-12 | $73.00K derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2015-03-31 | $377.00K 10-Q · filed 2016-05-12 | $377.00K derived: sum of 2 quarters · filed 2016-05-12 | $377.00K derived: sum of 3 quarters · filed 2016-05-12 | $73.00K derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $0.00 derived: sum of 2 quarters · filed 2016-03-10 | -$304.00K derived: sum of 3 quarters · filed 2016-03-10 | $73.00K 10-K · filed 2016-03-10 | ||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$304.00K derived: sum of 2 quarters · filed 2015-11-12 | $73.00K 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | -$304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $73.00K 10-Q · filed 2015-08-12 | ||||||
| 2014-03-31 | $377.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |